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Biosynthesis of the polyene antifungal antibiotic nystatin in
Streptomyces noursei ATCC 11455: analysis of the gene cluster
and deduction of the biosynthetic pathway
Trygve Brautaset1, Olga N Sekurova1, Håvard Sletta2, Trond E Ellingsen2,
Arne R Strøm1, Svein Valla1 and Sergey B Zotchev1
Background: The polyene macrolide antibiotic nystatin produced by
Streptomyces noursei ATCC 11455 is an important antifungal agent. The
nystatin molecule contains a polyketide moiety represented by a 38-membered
macrolactone ring to which the deoxysugar mycosamine is attached. Molecular
cloning and characterization of the genes governing the nystatin biosynthesis is
of considerable interest because this information can be used for the
generation of new antifungal antibiotics. 
Results: A DNA region of 123,580 base pairs from the S. noursei ATCC
11455 genome was isolated, sequenced and shown by gene disruption to be
involved in nystatin biosynthesis. Analysis of the DNA sequence resulted in
identification of six genes encoding a modular polyketide synthase (PKS),
genes for thioesterase, deoxysugar biosynthesis, modification, transport and
regulatory proteins. One of the PKS-encoding genes, nysC, was found to
encode the largest (11,096 amino acids long) modular PKS described to date.
Analysis of the deduced gene products allowed us to propose a model for the
nystatin biosynthetic pathway in S. noursei.
Conclusions: A complete set of genes responsible for the biosynthesis of the
antifungal polyene antibiotic nystatin in S. noursei ATCC 11455 has been
cloned and analyzed. This represents the first example of the complete DNA
sequence analysis of a polyene antibiotic biosynthetic gene cluster.
Manipulation of the genes identified within the cluster may potentially lead
to the generation of novel polyketides and yield improvements in the
production strains.
Introduction
Polyketides are natural products, many of which have
applied potential as pharmaceuticals. Examples of such
polyketides include erythromycin (antibacterial), nys-
tatin (antifungal), avermectin (antiparasitic), rapamycin
(immunosuppressant) and daunorubicin (antitumor).
The Gram-positive bacteria of the genus Streptomyces are
the main producers of polyketides, and the genetics and
biochemistry of polyketide biosynthesis in these organ-
isms are relatively well characterized [1]. Macrolide
polyketide compounds are formed via repeated conden-
sations of simple carboxylic acids by modular (type I)
polyketide synthases (PKSs) in a manner similar to fatty
acid biosynthesis. The modular hypothesis proposed by
Donadio et al. [2] suggested that type I PKSs are orga-
nized into repeated units (modules), each of which is
responsible for one condensation cycle in the synthesis
of a polyketide chain. This was proven to be correct by
manipulations of type I PKS genes resulting in pre-
dictable changes in the chemical structures of macrolides
[3]. Besides condensation of the next carboxylic acid onto
the growing polyketide chain, ensured by the catalytic
activity of a β-ketoacyl synthase (KS) domain, modules of
PKSs type I may contain domains with β-ketoreductase
(KR), dehydratase (DH), and enoyl reductase (ER) activi-
ties, which determine the reduced state of the incorpo-
rated extender unit. The acyltransferase (AT) and acyl
carrier protein (ACP) domains present in each module are
responsible for the choice of extender unit and retention
of the growing polyketide chain on the PKS, respectively.
Upon completion of synthesis, the polyketide chain is
released from the  PKS via the action of a thioesterase
(TE), which is probably also involved in cyclization of the
final product. The type I PKSs therefore represent an
assembly line for polyketide biosynthesis that can be
manipulated by changing the number of modules, their
specificities towards carboxylic acids, or by inactivating or
inserting domains with reductive activities [3]. After the
polyketide moiety is synthesized and cyclized to form a
macrolactone ring, it is usually modified via hydroxylation,
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glycosylation, methylation and/or acylation. These modifi-
cations are believed to be crucially important for the bio-
logical activities of macrolides. 
The genes for macrolide antibiotics biosynthesis in Strep-
tomyces are organized in clusters, making isolation of com-
plete sets of such genes relatively straightforward. Indeed,
exploitation of recombinant DNA technology makes it
possible to isolate complete antibiotic biosynthetic gene
clusters by screening gene libraries with DNA probes
encoding PKS fragments [1]. The molecular cloning and
complete DNA sequencing has been described for several
macrolide antibiotics produced by streptomycetes, includ-
ing those for avermectin, pikromycin and rapamycin [4–6].
The cloning and partial DNA sequencing of the gene
cluster for the polyene macrolide antibiotic pimaricin has
recently been reported [7].
Polyene macrolide antibiotics have 20–44-membered
lactone rings containing three to eight conjugated double
bonds. The latter structural feature most probably con-
tributes to the mode of action of these compounds, deter-
mined to be an interaction with sterols present in the
membranes of fungi [8]. Such an interaction leads to for-
mation of polyene–sterol complexes capable of organizing
themselves into transmembrane channels making the
membrane permeable to water and ions, leading to cell
death. Beside being antifungal agents, some of the
polyene antibiotics have been shown to have antibacterial,
antiviral and immunostimulating activities [9,10]. The
antibiotic nystatin A1 (Figure 1) is produced by the Gram-
positive bacterium Streptomyces noursei ATCC 11455, and
is used as an antifungal agent. The chemical structure of
nystatin suggests involvement of a type I PKS in the
biosynthesis of its macrolactone ring. Furthermore, it can
be predicted that the synthesis of the nystatin polyketide
chain starts with acetyl-CoA, and proceeds through con-
densation of three methylmalonyl-CoA and 15 malonyl-
CoA extender units. In this paper we describe the cloning
and analysis of the complete nystatin biosynthetic gene
cluster of S. noursei.
Results and discussion
Cloning of the nystatin biosynthetic gene cluster
In order to isolate the nystatin biosynthesis genes, we
probed a S. noursei gene library with labelled DNA encod-
ing a PKS. To obtain such a DNA probe, two degenerate
oligonucleotide primers were designed, corresponding to
conserved amino acid regions within KS and ACP domains
of known modular PKSs (see the Materials and methods
section). The polymerase chain reaction (PCR)-assisted
amplification of a DNA fragment from the S. noursei
genome with these primers was performed. Subsequent
cloning and DNA sequence analysis of the resulting
0.7 kb PCR product (see the Materials and methods
section) confirmed that it encodes part of a type I PKS.
This DNA fragment was used for screening the S. noursei
gene library constructed previously [11], and one recombi-
nant phage, designated DASHII-N1, which hybridized to
the probe, was isolated. 
Preliminary DNA sequence analysis of the N1 DNA
insert showed that it encodes a type I PKS. To confirm
the involvement of the cloned DNA in nystatin biosyn-
thesis, a 4.2 kb BamHI DNA fragment from the N1 insert
was used in a gene-disruption experiment as a part of the
suicide conjugative plasmid pKO(4.2)–1 (Table 1). One of
the resulting S. noursei disruption mutants, NCD3, carry-
ing pKO(4.2)–1 integrated into its genome (data not
shown) was unable to produce nystatin, thereby confirm-
ing the requirement of the identified PKS gene for nys-
tatin biosynthesis. This fragment was later shown to be an
internal part of the nysC gene (see below).
In order to clone a larger portion of the nystatin biosyn-
thetic gene cluster, the DNA fragments derived from the
ends of the DNA insert in phage N1, as well as those frag-
ments from overlapping recombinant phages, were used as
probes for screening the gene library. This ‘chromosome
walking’ resulted in isolation of recombinant phages
encompassing ~125 kb of the S. noursei genome (Figure 2).
DNA sequence and mutational analyses of the nystatin
PKS genes 
The complete DNA inserts from recombinant phages
were subcloned in Escherichia coli and sequenced. Com-
puter-assisted analysis of the DNA sequence (123,580 bp)
of the cloned region led to identification of the genes
shown in Figure 2 and listed in Table 2. Six genes, nysA,
nysB, nysC, nysI, nysJ and nysK, encoding a type I PKS were
identified. The amino acid (aa) sequences of the deduced
products encoded by these genes were analysed by com-
paring them to the aa sequences of known type I PKSs.
Because all six proteins were shown to share considerable
homology with rifamycin and rapamycin PKSs [12,13],
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Figure 1
Structure of the nystatin A1 molecule according to Lancelin and
Beau [36].
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presumptive functional analysis of the nystatin PKSs was
based on the comparison to the former polypeptides. The
predicted functional features of the NysA, NysB, NysC,
NysI, NysJ and NysK proteins are shown in Figure 3. 
The NysA protein most probably represents a loading
module involved in the initiation of the nystatin aglycone
biosynthesis. NysA contains a KS domain (KSS) similar to
that found in the presumed loading module of the
pimaricin PKS PIMS0 [7]. Both the NysA and PIMS0 pro-
teins are unusual in a sense that they represent the loading
modules only, whereas in all other type I PKSs character-
ized so far, loading modules are fused to the first condens-
ing module in multimodular polypeptides. The conserved
active-site cysteine residue in both NysA and PIMS0 KS
domains is replaced with a serine residue. In all the other
known inactive KSs (KSQ) in the loading modules of
type I PKSs, the conserved cysteine is replaced by gluta-
mine [14], except for the epothilone PKS loading module
KS, which bears a Cys→Tyr replacement [15]. Because
the aa sequence homology between the KSS domains in
NysA and PIMS0 (62.8%) is not higher than between the
NysA KSS and KS domains from other modular PKSs
(ranging from 49.9% to 64.6%), it seems unlikely that
these proteins have a recent common ancestor. It is tempt-
ing to speculate that the Cys→Ser replacement in the
active sites of KSS domains might have some significance
for NysA and PIMS0 functioning as separate loading
polypeptides. The latter might be related to the decar-
boxylase activity shown for the KSQ domains to be largely
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Table 1
Bacterial strains and plasmids used in this study.
Strain or plasmid Properties Source or reference
E. coli XL-1 Blue MRA(P2) Host for maintaining the gene library Stratagene
E. coli DH5α General cloning host BRL 
E. coli ET12567 Strain for intergeneric conjugation [37]
S. noursei ATCC 11455 Wild type (WT), nystatin producer ATCC
S. noursei NAD1 WT derivative with nysA disrupted by integration of pKNA1, nystatin nonproducer This work
S. noursei NBD2 WT derivative with nysB disrupted by integration of pKNB1, nystatin nonproducer This work
S. noursei NCD3 WT derivative with nysC disrupted by integration of pKO(4.2)–1, nystatin nonproducer This work
S. noursei NID1 WT derivative with nysI disrupted by integration of pKNI1, nystatin nonproducer This work
S. noursei NJD1 WT derivative with nysJ disrupted by integration of pKNJ1, nystatin nonproducer This work
S. noursei NRD2 WT derivative with nysRI disrupted by integration of pNRD2, nystatin nonproducer This work
pGEM3Zf(–) ColEI replicon, ApR, 3.2 kb Promega
pGEM11Zf(–) ColEI replicon, ApR, 3.2 kb Promega
pUZ8002 RK2 derivative, KmR, TcR D.H. Figurski*
pSOK201 pSG5 and ColEI replicons, oriT and AmR, 7.1 kb [11]
pPKS72 0.7 kb PCR product amplified from the S. noursei genome cloned in pUC18 This work
(see the Materials and methods section)
pL76S1.3 1.4 kb SalI fragment of nysA cloned in pGEM3Zf(–) This work
pKNA1 1.4 kb EcoRI–HindIII fragment from pL76S1.3 ligated with This work
the 3.0 kb EcoRI–HindIII fragment from pSOK201
pL76NB2.8 2.8 kb NotI–BamHI fragment of nysB cloned in pGEM11Zf(–) This work
pKNB1 2.8 kb BamHI–HindIII fragment from pL76NB2.8 ligated This work
with the 3.0 kb BamHI–HindIII fragment from pSOK201
pL64EB3.8 3.8 kb BamHI–EcoRI fragment from N64 (internal for nysI) cloned in pGEM3Zf(–) This work
pKNI1 3.8 kb EcoRI–HindIII fragment from pL64EB3.8 ligated This work
with the 3.0 kb BamHI–HindIII fragment from pSOK201
pL20EB3.7 3.7 kb BamHI–EcoRI fragment from N20 (internal for nysJ) cloned in pGEM3Zf(–) This work
pKNJ1 3.7 kb EcoRI–HindIII fragment from pL20EB3.7 ligated This work
with the 3.0 kb BamHI–HindIII fragment from pSOK201
pGEM4.2–1 4.2 kb BamHI fragment of nysC cloned in pGEM11Zf(–) This work
pKO(4.2)–1 4.2 kb EcoRI–HindIII fragment from pGEM4.2-1 ligated This work
with the 3.0 kb EcoRI–HindIII fragment from pSOK201
pNRD1 1.4 kb ApaI fragment of nysRI cloned in pGEM11Zf(–) This work
pNRD2 1.4 kb EcoRI–HindIII fragment from pNRD1 ligated with This work
the 3.0 kb EcoRI–HindIII fragment from pSOK201
Am, apramycin; Ap, ampicillin; Km, kanamycin; Tc, tetracycline. *Personal communication.
dependent on the presence of a glutamine residue in the
active site [14]. It has been suggested that KSQ domains in
the loading modules of modular PKSs might provide the
starter unit through the specific decarboxylation of
enzyme-bound extenders [14]. Because the significance of
the serine residue in the active sites of KSS domains for
their putative decarboxylase activity is not apparent, we
are planning to address this question experimentally.
Comparison of the NysA AT domain with its counterparts
from different PKSs suggested that it is acetate specific,
which correlates well with the structure of the nystatin
molecule. Interestingly, NysA contains an apparently
intact DH domain, which seems to serve no function, and
might just have been retained in this protein in the
process of evolution.
NysB apparently represents modules 1 and 2. The DH
domains in both of these modules lack the conserved
active-site motif H(X3)G(X4)P, due to large internal dele-
tions, and therefore must be inactive. The AT domains
identified within NysB display characteristic features of
the propionate-specific AT domains (mAT) [13,16].
These features of NysB support the assumption about its
involvement in first two elongation steps of the nystatin
polyketide moiety biosynthesis. 
The NysC protein, to our knowledge the largest bacterial
polypeptide discovered to date, is composed of six
modules apparently responsible for elongation steps 3–8 in
the nystatin polyketide chain formation. All AT domains in
NysC modules have features typical of the acetate-specific
ATs (data not shown). This correlates well with the
assumption that NysC incorporates six malonyl-CoA
extenders (C-32 to C-21) into the nystatin aglycone. The
only other protein with an organization similar to NysC,
the RAPS2 PKS of S. hygroscopicus, comprising six modules
and involved in rapamycin biosynthesis, is 873 aa shorter
than NysC. This difference can be explained by the more
compact structure of the RAPS2 domains and interdomain
linkers, because the overall number of modules and
domains, as well as their relevant positions in NysC and
RAPS2 match perfectly. The end-to-end alignment of the
NysC and RAPS2 aa sequences shows 49% identity — an
unusually high number considering the lengths of these
polypeptides. This, and the fact that rapamycin has an
antifungal activity and initially was classified as an atypical
polyene macrolide [17], might indicate that similarities
between NysC and RAPS2 are due to a common ancestor
from which the two proteins have evolved. 
The NysI protein is probably responsible for elongation
steps 9–14 of the nystatin polyketide backbone biosyn-
thesis. The presence of an mAT domain in module 11 is
consistent with incorporation of methylmalonyl-CoA
extender at this elongation step. The DH domains in
modules 10, 11, 12, 13 and 14 seem to be inactive due the
large internal deletions encompassing the active-site
motif (see above). The KR domain in module 13 of NysI
lacks the conserved motif aSRrG, and thus appears to be
inactive. The latter feature, together with inactive DH
domain in module 11, most probably account for the pres-
ence of a six-membered ketalic ring (between C-13 and
C-17) on the nystatin molecule (Figure 1). As judged from
the organization of modules in NysJ, the latter is required
for elongation steps 15–17 in nystatin macrolactone ring
assembly. The DH domain in module 16 contains a large
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Gene organization within the S. noursei ATCC 11455 nystatin
biosynthetic gene cluster. The inserts from the overlapping
recombinant phages encompassing the cloned region are shown
above the physical/genetic map. The nys genes are designated with
capital letters in italics, other ORFs are numbered. Stars above certain
ORFs indicate that these genes were successfully disrupted (see the
text and Table 1 for details).
internal deletion encompassing the active site, and the
conserved histidine residue in the module 17 DH domain
active site H(X3)G(X4)P is replaced with tyrosine. The
DH domains in modules 16 and 17 within NysJ therefore
appear to be inactive. The ER domain localized in
module 15 is probably responsible for the reduction of a
double bond between C-8 and C-9. The final 18th
module in the nystatin PKS system is represented by the
NysK protein, which lacks a KR domain, and contains an
apparently intact DH domain whose activity should not
be required at the last condensation step. We note that a
similar observation was made during analysis of the
rifamycin PKS, in which intact DH domains in modules 6
and 7 seem to be nonfunctional in the producing organism
[13]. A TE domain was identified at the carboxyl termi-
nus of NysK, suggesting that in addition to the condensa-
tion of the last extender unit, this protein also participates
in the release of the mature nystatin polyketide chain
from the PKS complex.
To confirm the involvement of nysA, nysB, nysI and nysJ
in nystatin biosynthesis, these genes were disrupted in
S. noursei via homologous recombination using the con-
jugative suicide vectors pKNA1, pKNB1, pKNI1, and
pKNJ1 (Table 1). All the disruption mutants obtained
(Table 1) were unable to produce nystatin, suggesting
that the genes mentioned above are essential for nystatin
biosynthesis. Even though the polar effects of the dis-
ruptions mentioned above cannot be ruled out, such
effects would imply that the genes affected are tran-
scribed as part of a polycistronic mRNA together with
the disrupted genes (see Figure 2). It seems highly
unlikely, therefore, that the disrupted genes themselves
have no role in nystatin biosynthesis. 
Immediately downstream of the nysC gene, a coding
sequence (nysE) for a TE was identified, providing yet
another example of two TE activities being localized in
the same antibiotic biosynthetic gene cluster. The 251 aa
NysE protein shows a high degree of homology (45%) to
the TEs encoded by the independent genes in the
pikromycin and tylosin biosynthetic gene clusters of Strep-
tomyces venezuelae and Streptomyces fradiae [6,17]. The NysE
polypeptide, however, does not display substantial homol-
ogy to the TE domains located at the carboxyl termini of
several modular PKSs. The precise role for the putative
TE encoded by nysE in nystatin biosynthesis remains
uncertain. Both the pikromycin and tylosin biosynthetic
gene clusters encode two TE activities, one of them
embedded in the PKS [6,18]. Although the exact func-
tions of these TEs are not clear, it was proposed that one
of them might be a ‘proof-reading’ enzyme, clearing off
certain substrates that would block further extension of
the chain by PKS [19,20]. 
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Table 2
Putative genes identified in the nystatin biosynthetic gene cluster of S. noursei.
Designation Product Putative function
nysA Type I PKS Nystatin PKS (loading module)
nysB Type I PKS Nystatin PKS (modules 1 and 2)
nysC Type I PKS Nystatin PKS (modules 3–8)
nysDI Glycosyltransferase Attachment of mycosamine 
nysDII Aminotransferase Mycosamine biosynthesis
nysDIII GDP-mannose-4,6-dehydratase Mycosamine biosynthesis
nysE Thioesterase Release of polyketide chain from PKS
nysF 4′-Phosphopantheteine transferase Post-translational PKS modification
nysG ABC transporter Efflux of nystatin
nysH ABC transporter Efflux of nystatin
nysI Type I PKS Nystatin PKS (modules 9–14)
nysJ Type I PKS Nystatin PKS (modules 15–17)
nysK Type I PKS Nystatin PKS (module 18 + TE)
nysL P450 monooxygenase Hydroxylation at C-10
nysM Ferredoxin Electron transfer in P450 system
nysN P450 monooxygenase Oxidation of methyl group at C-16
nysRI Transcriptional  activator Regulation of nystatin production
nysRII Transcriptional  activator Regulation of nystatin production
nysRIII Transcriptional  activator Regulation of nystatin production
ORF4 Transcriptional  activator Regulation
ORF3 Transcriptional  repressor Regulation
ORF2 Transcriptional  activator Regulation
Genes in the regulatory region 
The putative regulatory genes nysRI, nysRII and nysRIII
encoding polypeptides of 966 aa, 953 aa and 927 aa,
respectively, were identified downstream of nysE. The
deduced products of these genes are homologous to the
transcriptional regulators found in the vicinity of the
cholesterol oxidase–cytochrome P450 operon of Strepto-
myces sp. SA-COO [21]. To confirm the involvement of
nysRI in nystatin biosynthesis, this gene was disrupted in
S. noursei with the suicide vector pNRD2 (Table 1).
Analysis of the secondary metabolites produced by the
corresponding mutant NRD2 revealed that it cannot
synthesize nystatin. Because the nysRII and nysRIII
genes are located just downstream of nysRI, and are tran-
scribed in the same direction, it is plausible that the
nysRI disruption has a polar effect on transcription of
these genes. 
Downstream of nysRIII, three ORFs (ORFs 2–4) were
identified that might be involved in the regulation of
nystatin biosynthesis. The deduced ORF4 product of
210 aa is similar to the transcriptional activators of
response regulator type, whereas a 253 aa polypeptide
encoded by ORF3 shows considerable homology to the
transcriptional repressors of the DeoR family [22]. ORF2,
located downstream of ORF3, and transcribed in the
opposite direction, encodes a putative polypeptide of
354 aa that is similar to the transcriptional activators of
the AsnC family [23]. Experiments aimed at mutational
analysis of all the regulatory genes associated with the
gene cluster are currently under way, and will provide
the answer as to their involvement in the process of nys-
tatin biosynthesis. 
Sequencing of an additional 5 kb DNA from the phage
N69 insert extending the cloned region to the right from
ORF2 (data not shown) identified several genes
for peptide metabolism (T.B. and S.B.Z., unpublished
observations) for which no role in nystatin biosynthesis
could be assigned. This observation suggests that the
right border of the nystatin biosynthetic gene cluster has
been identified. 
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Functional organization of the nystatin PKS including the NysA, NysB,
NysC, NysI, NysJ and NysK proteins. KS, ketosynthase;
KSS, ketosynthase with the Cys→Ser substitution in the active site;
AT, acetate-specific acyltransferase; mAT, propionate-specific
acetyltransferase; DH, dehydratase; DHi, inactive dehydratase;
ER, enoyl reductase; KR, ketoreductase; KRi, inactive ketoreductase;
ACP, acyl carrier protein.
Putative mycosamine biosynthesis genes 
Three genes presumably involved in biosynthesis and
attachment of the mycosamine moiety were found in the
cluster (Figure 2; Table 2). The 506 aa-long nysDI
product shows considerable homology to the eukaryotic
UDP-glucuronosyltransferases. The latter enzyme
belongs to the UDP-glycosyltransferase family, and is
involved in eliminating potentially toxic xenobiotics by
the way of their glycosylation [24]. It seems likely that
NysDI represents a glycosyltransferase responsible for
the attachment of the deoxysugar moiety (mycosamine)
to the nystatin aglycone at C-19. The deduced product of
nysDII (352 aa) is highly similar to perosamine syn-
thetases from different bacteria. The latter enzyme cat-
alyzes conversion of GDP-4-keto-6-deoxy-D-mannose to
4-NH2-4,6-dideoxy-D-mannose in the biosynthesis of per-
osamine, which constitutes the backbone structural unit
of the lipopolysaccharide O-antigens in pathogenic bacte-
ria [25]. Because the nystatin deoxysugar moiety
mycosamine contains an amino group, it is plausible that
NysDII represents an aminotransferase involved in
mycosamine biosynthesis. The nysDIII gene encodes a
344 aa protein similar to GDP-mannose-4,6-dehydratases,
and is therefore probably responsible for one of the initial
steps in mycosamine biosynthesis. The fact that NysDIII
more closely resembles the GDP-mannose-4,6-dehy-
dratases than the TDP-glucose-4,6-dehydratases (Gdh)
suggests that the mycosamine biosynthetic pathway in
S. noursei differs from those of other antibiotics’ deoxy-
sugar moieties. This would also explain why our initial
attempt to identify the nystatin gene cluster using a Gdh-
specific DNA probe failed [11]. The presence of only two
deoxysugar biosynthesis genes in the cluster might be
explained by the key roles played by the corresponding
enzymes in mycosamine biosynthesis. All other enzymes
required for this deoxysugar formation can, in principle, be
recruited from different (i.e. primary) metabolic pathways. 
Modification and transport genes
Three genes encoding proteins presumably involved in
modification of the nystatin molecule were identified
between nysK and nysDII (Figure 2). Both the nysL and
nysN genes encode P450 monooxygenases of 394 aa and
398 aa, respectively, that are probably responsible for
hydroxylation of the nystatin polyketide moiety at C-10,
and oxidation of the methyl group at C-16. Which protein
is responsible for which reaction is not clear at the
moment, and additional experiments are required for
exact placement of NysL and NysN in the nystatin
biosynthetic pathway. The nysM gene apparently encodes
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Proposed model for nystatin biosynthesis in S. noursei.
a ferredoxin of 64 aa, which presumably constitutes a part
of one or both P450 monooxygenase systems, and serves
as an electron donor [26].
The nysH and nysG genes localized upstream of nysDIII
encode 584 aa and 605 aa polypeptides, respectively. Both
NysH and NysG display high degrees of similarity to
transporters of the ABC family [27], and thus might be
involved in ATP-dependent efflux of nystatin.
Downstream of nysG, a putative nysF gene was identified
whose 245 aa product is homologous to the 4′-phospho-
pantheteine transferases. The latter enzyme carries out
the post-translational modification of the ACP domains on
the PKSs, which is required for their full functionality
[28]. It seems likely, therefore, that the NysF protein
functions in modification of the nystatin PKS and is
important for the nystatin biosynthesis. DNA sequencing
and analysis of the insert in phage N90, which extends the
characterized region by ~10 kb to the left of nysF, identi-
fied genes for signal peptidase, and other proteins with no
possible role in nystatin biosynthesis (T.B. and S.B.Z.,
unpublished observations). The putative nysF gene there-
fore marks the left border of the nystatin biosynthetic
gene cluster in S. noursei. 
Proposed model for the nystatin biosynthetic pathway of
S. noursei 
Based on the information derived from the analysis of the
genes found in the nystatin biosynthetic gene cluster we
propose a model for synthesis of this antibiotic in the pro-
ducing organism S. noursei (Figure 4). The synthesis starts
with loading of the acetyl-CoA onto the NysA protein, and
proceeds through condensation of three methylmalonyl-
CoA and 15 malonyl-CoA extender units by NysB, NysC,
NysI, NysJ and NysK PKS. After cleavage of the mature
polyketide chain from the PKS complex by the TE domain
of NysK, the chain is cyclized to form the nystatin agly-
cone. The next two steps in the nystatin biosynthesis are
probably accomplished by the NysL and NysN monooxy-
genases, which perform hydroxylation and oxidation of the
macrolactone ring at C-10 and C-16, respectively. 
Biosynthesis of mycosamine presumably starts with
the L-fructose-6-phosphate, which is converted to
GDP-D-mannose through the action of a phosphomannoi-
somerase, phosphomannomutase, and a GDP–mannose
pyrophosphorylase. These enzymes are involved in
primary metabolic pathways for cell-surface lipopolysac-
charide biosynthesis in many bacteria [25], and the genes
for the two former have been located on the chromosome
of S. coelicolor A3(2) during the genome sequencing effort.
It seems likely, therefore, that there is interplay between
the primary and secondary metabolisms in S. noursei
during mycosamine biosynthesis, although it is not appar-
ent how the regulation of such genes is coordinated. The
GDP-D-mannose probably serves as a substrate for the
NysDIII protein, which converts it to the GDP-4-keto-6-
deoxy-D-mannose. A GDP-3-keto-6-deoxy-D-mannose
isomerase must perform the next step in mycosamine
biosynthesis, probably followed by the NysDII-mediated
amidation leading to formation of GDP-mycosamine. The
NysDI protein, a putative glycosyltransferase, presumably
completes the pathway by attaching the mycosamine
moiety to the modified nystatin aglycone.
The model presented above is based on the assumption
that both monooxygenases modify the nystatin macrolac-
tone ring prior to its glycosylation. Whether this is true will
be verified by the ongoing experiments on inactivation of
the nysL and nysN genes, and structural analysis of the nys-
tatin derivatives produced by the corresponding mutants. 
Significance
Analysis of the Streptomyces noursei nystatin biosynthetic
gene cluster carried out in this study provides useful
information with regard to the genes governing synthesis
of this important antifungal agent. Functional assign-
ments for the proteins encoded within the cluster suggest
a model for the nystatin biosynthetic pathway, and open
possibilities for genetic manipulations with the aim of pro-
ducing novel nystatin derivatives. Identification of several
putative regulatory genes associated with the cluster,
along with data on inactivation of one potential regulator,
imply that they can be used for enhancing the yield of
nystatin (and probably its derivatives) in fermentations. 
Materials and methods 
Bacterial strains, plasmids and growth conditions 
Bacterial strains and plasmids used in this study are listed in Table 1.
S. noursei ATCC 11455 and its mutants were grown on solid ISP2
medium (Difco), and in liquid TSB medium (Oxoid). Intergeneric conju-
gation from E. coli ET12567 (pUZ8002) into Streptomyces strains was
done as reported elsewhere [29], but with the ‘heat shock’ time
reduced to 5 min. E. coli strains were grown and transformed as
described by others [30], except for E. coli ET12567 (pUZ8002),
which was maintained on media with 20 µg/ml chloramphenicol and 50
µg/ml kanamycin. Analysis of the nystatin production by S. noursei
strains was performed in SAO-23 liquid medium [31]. 
DNA manipulations
Plasmid, phage and total DNA preparations, endonuclease digestions
and ligations were performed as described previously [30,32]. DNA
fragments were isolated from agarose gels using the QIAGEN Kit
(QIAGEN GmbH, Germany), labelled with the use of the digoxygenin
kit from Boehringer Mannheim, and used for Southern blot analysis
according to the manufacturer’s instructions. Genotypes of all disrup-
tion mutants obtained in the course of this study (Table 1) were verified
by Southern blot analysis (data not shown). DNA sequencing was per-
formed at QIAGEN GmbH, and the data were analyzed with the Frame-
Plot 2.3 online program [33] and GCG software [34]. 
Amplification of a PKS-encoding DNA fragment used for
screening of the S. noursei gene library
Degenerate primers used for amplification of a PKS-encoding DNA
fragment corresponded to the conserved aa motifs in ACP and KS
domains in known type I PKSs, and were designed according to the
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codon usage table for Streptomyces [35]. The ACP oligonucleotide
primer (sense) had the sequence 5′-GAG/C CTG/C GGC/G T/CTG/C
GAC TCC/G CTG/C-3′, and the KS oligonucleotide primer (antisense)
had the sequence 5′-G/CGA G/CGA G/ACA G/CGC C/GGT GTC
G/CAC-3′. The 50 µl PCR mixture contained: 0.1 µg S. noursei ATCC
11455 genomic DNA, 25 pm each ACP and KS oligonucleotide
primers, dNTPs (final concentration 350 µm), 1× PCR buffer from
Expand High Fidelity PCR System (Boehringer Mannheim), and 1.5 U
of the DNA polymerase mixture from the same system. The PCR was
performed on the Perkin Elmer GeneAmp PCR System 2400 with the
following program: 1 cycle of denaturation at 96°C (4 min), 35 cycles of
denaturation/annealing/synthesis at 94°C (45 s) and 70°C (5 min), and
1 cycle of final annealing/extension at 72°C (7 min). The 0.7 kb DNA
fragment obtained with this procedure was cloned in pUC18 with the
use of SureClone Ligation Kit (Pharmacia). One of the resulting recom-
binant plasmids, pPKS72, was subjected to DNA sequence analysis,
and later used for primary screening of the S. noursei gene library. 
Accession numbers
The DNA sequence reported here was deposited in GenBank under
the accession number AF263912.
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